HEALTH OF WOMAN.2017.1(117):101–108; doi 10.15574/HW.2017.117.101

Grishchenko O. V., Bobrytska V. V., Chernyak O. L.
Kharkiv medical Academy of postgraduate education

The objective: to optimize treatment of endometriosis using a combined hormonal Luvyna medicine.

Materials and methods. The study included 50 patients 22-36 years old with a diagnosis of endometriosis. In line with the patient’s therapy are divided into groups: I group (n = 25) received the Luvyna on a continuous 63/7 scheme, then 3 months in scheme 21/7; group II (n = 25) after surgical treatment of endometriosis (gistero-, laparoscopy) also received the medicine in a similar way. The mode of menstrual function disorders, pain on a visual rating scale of pain, psycho-emotional status, concomitant dysfunction of adjacent organs were evaluated.

Results. According to the results of therapy established algodismenorei reduction in symptoms I group – 80%, II – 83%, abnormal uterine bleeding I – 96%, II – 100%; the disappearance of heavy uterine bleeding, improving the function of adjacent organs, psycho-emotional status in both groups. Reduced pain on a pain scale from 8±2.0 to 2±0.5 in the group I and from 7±2.5 to 1±1.0 in the group II.

Conclusion. Luvina is a highly effective medicine for the treatment of endometriosis, comparable to the combined treatment – surgery, followed by the appointment of combined oral contraceptives. Recommended mode 63/7, followed by a reception 21/7, including after surgical treatment.

Key words: endometriosis, Luvyna, conservative therapy, combined therapy.

REFERENCES

1. Taktika vedennya patsientok z endometriozom. Adaptovana klinichna nastanova. K. 2016:118.

2. Unifikovaniy klinichniy protokol pervinnoyi, vtorinnoyi (spetsializovanoyi) ta tretinnoyi (visokospetsializovanoyi) medichnoyi dopomogi «Taktika vedennya patsientok z genitalnim endometriozom»/ Nakaz MOZ Ukrayini № 319 vid 06.04.2016.

3. Gerasimov AM. 2007. Prichinyi besplodiya pri naruzhnom endometrioze. Probl. reprod. 3:66–69.

4. Marzhevskaya AM, Rischuk SV, Gusev SN, Tatarova NA i soavt. 2014. Reproduktivnyie narusheniya u bolnyih endometriozom: etiologiya, patogenez, vozmozhnosti korrektsii. Byulleten Orenburg nauchnogo tsentra Uro RAN (elektronnyiy zhurnal). 3:1–42.

5. Ozhiganova IN. 2014. Morfologiya raka yaichnikov v klassifikatsii VOZ 2013 goda. Prakticheskaya onkologiya 15;4:143–152.

6. Prilepskaya VN, Ivanova EV, Tagieva AV, Letunovskaya AB. 2012. Endometrioz: ot trudnostey diagnostiki k novyim vozmozhnostyam terapii. Consilium Medicum. 4:4–8.

7. Prilepskaya VN. 2010. Endometrioz i reproduktivnoe zdorove zhenschin. Akusherstvo, ginekologiya i reproduktsiya 4;3.

8. Unanyan AL. 2010. Endometrioz i reproduktivnoe zdorove zhenschin. Akusherstvo, ginekologiya, reproduktologiya 4;3:6–11.

9. Serebrennikova KG, Kuznetsova EP, Lapshihin AA, Ivanova TV, Hmelevskaya VF i soavt. 2012. Reabilitatsiya reproduktivnoy funktsii zhenschin posle operativnogo lecheniya na yaichnikah. Mediko-sotsialnaya ekspertiza i reabilitatsiya 1:18–22.

10. Sahautdinova IV, Mustafina GT, Habibullina RN, Yarkina EI i soavt. 2015. Sovremennyie metodyi diagnostiki i lecheniya endometrioza yaichnikov. Meditsinskiy vestnik Bashkortostana 10;1:113–115.

11. Bulun SE. 2009. Endometriosis. N EnglJ Med 360:268–79. https://doi.org/10.1056/NEJMra080469; PMid:19144942

12. Kennedy S, Bergqvist A, Chapron C, D’Hooghe T, Dunselman G, Greb R, Hummelshoj L, Prentice A, Saridogan E. 2005. ESHRE Special Interest Group for Endometriosis and Endometrium Guideline Development Group. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod 20:2698–2704. https://doi.org/10.1093/humrep/dei135; PMid:15980014

13. Meuleman C, Hoor AD, Van Cleynenbreugel B, Tomassetti S, Hoogh TD. 2011. Why we need international agreement on terms and definitions to assess clinical outcome after endometriosis surgery. Hum Reprod. 26(6):1598–1599. https://doi.org/10.1093/humrep/der098; PMid:21478183

14. Nnoaham K, Hummelshoj L, Webster P, D’Hooghe T, de Cicco Nardone F, de Cicco Nardone C, Jenkinson C, Kennedy SH, Zondervan KT. 2011. World Endometriosis Research Foundation Global Study of Women. Impact of endometriosis on quality of life and work productivity: A multi-centre study across 10 countries. Fertil Steril. 96:366–373. https://doi.org/10.1016/j.fertnstert.2011.05.090; PMid:21718982 PMCid:PMC3679489

15. Simoens S, Dunselman G, Dirksen C, Hummelshoj L, Bokor A, Brandes I, Brodszky V, Canis M, Colombo GL, DeLeire T et al. 2012. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum Reprod 27:1292–1299. https://doi.org/10.1093/humrep/des073; PMid:22422778

16. Strowitzki et all. 2010. Dienogest in the treatment of endometriosis-associated pelvic pain: A 12-week, randomized, double-blind, placebocontrolled study. Eur J Obstet Gynecol Reprod Biol. 151(2):193–198.

17. Tomassetti C, Meuleman C, Pexsters A. 2006. Endometriosis recurrent miscarriage and implantation failure: is there an immunologial link? Reprod. Biomed. Online. 13;1:58–64. https://doi.org/10.1016/S1472-6483(10)62016-0

18. Endometriosis: Diagnosis and Management. JOGC. 2010:1–27.